一种天然的有机化合物"德库辛"具有抗瘤和脏保护作用:治疗骨髓瘤的治疗方法
Daichi Hayashi1, Toshiharu Shirai1, Ryu Terauchi1
1Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.
Journal of oncology
|December 22, 2023
概括
德库尔辛对骨质肉瘤有抗瘤作用,并保护原诱导的脏损伤. 这种天然化合物增强化疗效率,减少副作用,提供了一个有前途的治疗选择.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 骨髓瘤是一种罕见的儿科癌症,通常用西斯普拉丁治疗,这可能会导致严重的损伤.
- 迪库辛是一种生物活性化合物,具有已知的抗炎,抗氧化和抗瘤特性,但其在骨髓瘤和西斯甲毒性中所起的作用尚不清楚.
研究的目的:
- 调查德库尔辛在骨髓瘤中增强西斯的抗瘤活性的潜力.
- 评估德库西因对西斯普拉丁诱导的毒性产生的保护作用.
主要方法:
- 在体外研究中评估了细胞活力,IC50,细胞亡,细胞周期和Akt路径调节.
- 在体内研究评估了decursin对小鼠骨髓瘤瘤生长和功能的影响.
- 西斯普拉丁和德库尔辛的联合治疗在体外和体内都被评估.
主要成果:
- 通过影响细胞循环和抑制Akt通路,Decursin抑制了骨髓瘤细胞活力,并诱导了细胞亡.
- 结合德库尔辛和西斯普拉丁治疗增强了亡,降低了细胞活力,并比单独使用西斯普拉丁更有效地抑制了瘤生长.
- 迪库尔辛减轻了西斯普拉丁诱导的功能障碍和上皮细胞损伤.
结论:
- 德库尔辛对骨髓瘤细胞表现出显著的抗瘤活性.
- 德库尔辛在与西斯普拉丁结合时表现出脏保护作用.
- 德库尔辛是骨髓瘤的潜在治疗剂,可以提高治疗效率,减少化疗相关的毒性.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
208
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
208
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


